| 今开：0.0 | 昨收：0.378 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1418101.0 |
NeuBase Therapeutics(NBSE)05-14 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-04 04:15
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-067779 Act: 34 Size: 943 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)04-06 04:25
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001104659-24-044287 Act: 34 Size: 214 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-14 18:05
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060759 Act: 34 Size: 18 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-04 04:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-24-056957 Act: 34 Size: 206 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)04-10 04:05
$NeuBase Therapeutics(NBSE)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-045207 Act: 34 Size: 1 MB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-01 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-24-067212 Act: 34 Size: 291 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-16 22:15
$NeuBase Therapeutics(NBSE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000350 Act: 34 Size: 3 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-23 05:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-064320 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-06 19:35
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-057213 Act: 34 Size: 19 KB 网页链接查看全文
药时代2022-10-20 14:32
前言
心理学告诉人们，永远不要在晚上做决定，因为那是不理性的。
但我不听劝（决定玩会手机），打开手机，又一则关于裁员的新闻弹出，让我陷入了思考。
我焦虑了，也失眠了。
新闻的题目是：“NeuBase放弃了亨廷顿舞蹈症，消减60%的劳动力作为战略支点”
还贴心附了...查看全文
$NeuBase疗法(NBSE)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-09-13 AccNo: 0001387131-19-006938 Size: 413 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-27 AccNo: 0001786406-19-000001 Size: 6 KB 网页链接
$NeuBase疗法(NBSE)$ 8-K - Current report Filed: 2019-08-14 AccNo: 0001387131-19-006142 Size: 47 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$NeuBase疗法(NBSE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001387131-19-006165 Size: 2 MB 网页链接
$NeuBase疗法(NBSE)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-16 AccNo: 0001387131-19-006228 Size: 412 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-22 AccNo: 0001387131-19-005253 Size: 58 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-07-22 AccNo: 0001387131-19-005254 Size: 55 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-22 AccNo: 0001387131-19-005251 Size: 50 KB 网页链接
$NeuBase疗法(NBSE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-18 AccNo: 0001535384-19-000009 Size: 423 KB 网页链接
$NeuBase疗法(NBSE)$ 8-K/A [Amend] - Current report Filed: 2019-07-17 AccNo: 0001387131-19-005158 Size: 90 KBItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...